Literature DB >> 17878394

Autoantibodies in canine masticatory muscle myositis recognize a novel myosin binding protein-C family member.

Xiaohua Wu1, Zhi-fang Li, Randolph Brooks, Elizabeth A Komives, Justin W Torpey, Eva Engvall, Steven L Gonias, G Diane Shelton.   

Abstract

Inflammatory myopathies are a group of autoimmune diseases that affect muscles. In humans, the most common inflammatory myopathies are polymyositis, dermatomyositis, and inclusion body myositis. Autoantibodies may be found in humans with inflammatory myopathies, and these play an important role in diagnosis and disease classification. However, these Abs are typically not muscle specific. Spontaneously occurring canine inflammatory myopathies may be good parallel disorders and provide insights into human myositis. In dogs with inflammatory myopathy, muscle-specific autoantibodies have been found, especially in masticatory muscle myositis. We have identified the major Ag recognized by the autoantibodies in canine masticatory muscle myositis. This Ag is a novel member of the myosin binding protein-C family, which we call masticatory myosin binding protein-C (mMyBP-C). mMyBP-C is localized not only within the masticatory muscle fibers, but also at or near their cell surface, perhaps making it accessible as an immunogen. The gene for mMyBP-C also exists in humans, and mMyBP-C could potentially play a role in certain human inflammatory myopathies. Understanding the role of mMyBP-C in this canine inflammatory myopathy may advance our knowledge of mechanisms of autoimmune inflammatory muscle diseases, not only in dogs, but also in humans.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17878394     DOI: 10.4049/jimmunol.179.7.4939

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  7 in total

1.  Expression of masticatory-specific isoforms of myosin heavy-chain, myosin-binding protein-C and tropomyosin in muscle fibers and satellite cell cultures of cat masticatory muscle.

Authors:  Lucia H D Kang; Agita Rughani; Matthew L Walker; Rosa Bestak; Joseph F Y Hoh
Journal:  J Histochem Cytochem       Date:  2010-03-30       Impact factor: 2.479

2.  Cross-bridge kinetics of fast and slow fibres of cat jaw and limb muscles: correlations with myosin subunit composition.

Authors:  Joseph F Y Hoh; Zhao-Bo Li; Han Qin; Michael K H Hsu; Gunther H Rossmanith
Journal:  J Muscle Res Cell Motil       Date:  2008-03-05       Impact factor: 2.698

3.  Clinical features of idiopathic inflammatory polymyopathy in the Hungarian Vizsla.

Authors:  Anna Tauro; Diane Addicott; Rob D Foale; Chloe Bowman; Caroline Hahn; Sam Long; Jonathan Massey; Allison C Haley; Susan P Knowler; Michael J Day; Lorna J Kennedy; Clare Rusbridge
Journal:  BMC Vet Res       Date:  2015-04-21       Impact factor: 2.741

4.  A missense mutation in MYH1 is associated with susceptibility to immune-mediated myositis in Quarter Horses.

Authors:  Carrie J Finno; Giuliana Gianino; Sudeep Perumbakkam; Zoë J Williams; Matthew H Bordbari; Keri L Gardner; Erin Burns; Sichong Peng; Sian A Durward-Akhurst; Stephanie J Valberg
Journal:  Skelet Muscle       Date:  2018-03-06       Impact factor: 4.912

5.  Leishmania spp.-Infected Dogs Have Circulating Anti-Skeletal Muscle Autoantibodies Recognizing SERCA1.

Authors:  Francesco Prisco; Davide De Biase; Giuseppe Piegari; Francesco Oriente; Ilaria Cimmino; Valeria De Pasquale; Michele Costanzo; Pasquale Santoro; Manuela Gizzarelli; Serenella Papparella; Orlando Paciello
Journal:  Pathogens       Date:  2021-04-12

6.  Clinical presentation, MRI, histopathology and outcome in a cat with immune-mediated masticatory myositis.

Authors:  Marco Armellini; Lluís Sánchez; Andrea Lorek; G Diane Shelton; Luisa De Risio
Journal:  JFMS Open Rep       Date:  2021-10-06

Review 7.  A scoping review of autoantibodies as biomarkers for canine autoimmune disease.

Authors:  Amy E Treeful; Emily L Coffey; Steven G Friedenberg
Journal:  J Vet Intern Med       Date:  2022-02-22       Impact factor: 3.333

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.